Futura Medical Regulatory News (FUM)

3 Jan 2008 08:00

Futura Medical PLC03 January 2008 For immediate release 3 January 2008 Futura Medical plc ("Futura" or "the Company") Director's Share Transfer Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovativeproducts for consumer healthcare, announces the following transfer of ordinaryshares in the Company by Anthony Clayden, Finance Director. There is no changein Mr Clayden's total shareholding in the Company as a result of the transfer. On 2 January 2008, Mr Clayden sold 30,000 ordinary shares in the Company at45.9p a share and on the same day 30,000 ordinary shares were purchased at 46p ashare by Mr Clayden's Self Invested Personal Pension account held in aHargreaves Lansdown Vantage SIPP. For further information: Futura Medical plcJames Barder, Chief Executive Tel: +44 (0) 1483 685 670mail to: www.futuramedical.co.ukjames.barder@futuramedical.co.uk Media enquiries:Buchanan CommunicationsMark Court / Rebecca Skye Dietrich Tel: +44 (0) 20 7466 5000 Nominated Adviser:Canaccord Adams LimitedMark Williams / Erin Needra Tel: +44 (0) 20 7050 6500 This information is provided by RNS The company news service from the London Stock Exchange